Alaunos Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.37

+0.29 (+13.94%)

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +1,631.2% upside

Low Target $36.60

Average Target $41.03

High Target $68.97

Current Price $2.37

Current
$2.37

Target
$41.03

$36.60 $41.03 avg $68.97

Scenario Analysis

Bear Case

$36.60

1,444.3%

Low target

Base Case

$41.03

+1,631.2%

Avg target

Bull Case

$68.97

+2,810.1%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$6.20

-61.8% from high

52-Week Low

$1.67

+41.9% from low

Target vs 52W High

$41.03

+561.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+1.3%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.1%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-12.3%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.1%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-40.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.5%